Association of serum lipids and coronary artery disease with polymorphisms in the apolipoprotein AI-CIII-AIV gene cluster

References

• Aalto-Setälä, K., Weinstock, P. H., Bisgaier, C. L., Wu, L., Smith, J. D., & Breslow, J. L. (1996). Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice. Journal of Lipid Research, 37, 1802–1811.
   Google Scholar
• Agrawal, S., & Mastana, S. (2014). Genetics of coronary heart disease with reference to ApoAI-CIII-AIV gene region. World Journal of Cardiology, 6, 755–763.10.4330/wjc.v6.i8.755
   Google Scholar
• Ascaso, J. F., Fernández-Cruz, A., González Santos, P., Hernández Mijares, A., Mangas Rojas, A., Millán, J., … Pintó, X. (2004). HDL Forum. Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: Recommendations of the HDL Forum. American Journal of Cardiovascular Drugs, 4, 299–314.10.2165/00129784-200404050-00003
   Google Scholar
• AshokKumar, M., Subhashini, N. G., SaiBabu, R., Ramesh, A., Cherian, K. M., & Emmanuel, C. (2010). Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians. Molecular Biology Reports, 37, 521–527.10.1007/s11033-009-9728-7
   Google Scholar
• Barter, P. J., Nicholls, S., Rye, K. A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004). Antiinflammatory properties of HDL. Circulation Research, 95, 764–772.10.1161/01.RES.0000146094.59640.13
   Google Scholar
• Begom, R., & Singh, R. B. (1995). Prevalence of coronary artery disease and its risk factors in the urban population of South and North India. Acta Cardiologica, 50, 227–240.
   Google Scholar
• Breslow, J. L. (1995). Familial disorders of high density lipoprotein metabolism. In C. R. Scriver, A. L. Beaudet, W. S. Sly, & D. Valle (Eds.), The metabolic basis of inherited disease (pp. 1251–1266). New York: McGraw-Hill.
   Google Scholar
• Chhabra, S., Narang, R., Krishnan, L. R., Vasisht, S., Agarwal, D. P., Srivastava, L. M., … Das, N. (2002). Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians. BMC Genetics, 3, 9.10.1186/1471-2156-3-9
   Google Scholar
• Chhabra, S., Narang, R., Lakshmy, R., Vasisht, S., Agarwal, D. P., Srivastava, M., … Das, N. (2004). Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD. Molecular and Cellular Biochemistry, 259, 59–66.10.1023/B:MCBI.0000021345.31556.c9
   Google Scholar
• Cohen, R. D., Castellani, L. W., Qiao, J. H., Van Lenten, B. J., Lusis, A. J., & Reue, K. (1997). Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. Journal of Clinical Investigation, 99, 1906–1916.10.1172/JCI119358
   Google Scholar
• Dammerman, M., Sandkuijl, L. A., Halaas, J. L., Chung, W., & Breslow, J. L. (1993). An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. Proceedings of the National Academy of Sciences, 90, 4562–4566.10.1073/pnas.90.10.4562
   Google Scholar
• Duverger, N., Tremp, G., Caillaud, J. M., Emmanuel, F., Castro, G., Fruchart, J. C., … Denefle, P. (1996). Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science, 273, 966–968.10.1126/science.273.5277.966
   Google Scholar
• Dvorin, E., Gorder, N. L., Benson, D. M., & Gotto, Jr., A. M. (1986). Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. Journal of Biological Chemistry, 261, 15714–15718.
   Google Scholar
• Excoffier, L., Laval, G., & Schneider, S. (2005). Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online, 1, 47–50.
   Google Scholar
• Fisher, R. M., Burke, H., Nicaud, V., Ehnholm, C., & Humphries, S. E. (1999). Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. Journal of Lipid Research, 40, 287–294.
   Google Scholar
• Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clinical Chemistry, 18, 499–502.
   Google Scholar
• Ghiselli, G., Krishnan, S., Beigel, Y., & Gotto, A. M. (1986). Plasma metabolism of apolipoprotein A-IV in humans. Journal of Lipid Research, 27, 813–827.
   Google Scholar
• Goldberg, I. J., Scheraldi, C. A., Yacoub, L. K., Saxena, U., & Bisgaier, C. L. (1990). Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. Journal of Biological Chemistry, 265, 4266–4272.
   Google Scholar
• Groenendijk, M., Cantor, R. M., Blom, N. H., Rotter, J. I., De Bruin, T. W., & Dallinga-Thie, G. M. (1999). Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia. Journal of Lipid Research, 40, 1036–1044.
   Google Scholar
• Guyard-Dangremont, V., Lagrost, L., & Gambert, P. (1994). Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity. Journal of Lipid Research, 35, 982–992.
   Google Scholar
• Heng, C. K., Low, P. S., & Saha, N. (2001). Variations in the promoter region of the Apolipoprotein A-1 Gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore. Pediatric Research, 49, 514–518.10.1203/00006450-200104000-00013
   Google Scholar
• Hixson, J. E., & Powers, P. K. (1991). Restriction isotyping of human apolipoprotein A-IV: Rapid typing of known isoforms and detection of a new isoform that deletes a conserved repeat. Journal of Lipid Research, 32, 1529–1535.
   Google Scholar
• Jeenah, M., Kessling, A., Miller, N., & Humphries, S. (1990). G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Molecular Biology & Medicine, 7, 233–241.
   Google Scholar
• Jong, M. C., Hofker, M. H., & Havekes, L. M. (1999). Role of ApoCs in lipoprotein metabolism: Functional differences between ApoC1, ApoC2, and ApoC3. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 472–484.10.1161/01.ATV.19.3.472
   Google Scholar
• Kamboh, M. I., Bunker, C. H., Aston, C. E., Nestlerode, C. S., McAllister, A. E., & Ukoli, F. A. (1999). Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks. Genetic Epidemiology, 16, 205–222.10.1002/(ISSN)1098-2272
   Google Scholar
• Kessling, A. M., Horsthemke, B., & Humphries, S. E. (1985). A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidemic and normal individuals. Clinical Genetics, 28, 296–306.
   Google Scholar
• Kretowski, A., Hokanson, J. E., McFann, K., Kinney, G. L., Snell-Bergeon, J. K., Maahs, D. M., … Li, J. (2006). The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes. Diabetologia, 49, 1946–1954.10.1007/s00125-006-0317-1
   Google Scholar
• Kronenberg, F., Stühlinger, M., Trenkwalder, E., Geethanjali, F. S., Pachinger, O., von Eckardstein, A., & Dieplinger, H. (2000). Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. Journal of the American College of Cardiology, 36, 751–757.10.1016/S0735-1097(00)00775-0
   Google Scholar
• Larson, I. A., Ordovas, J. M., Barnard, J. R., Hoffmann, M. M., Feussner, G., Lamon-Fava, S., & Schaefer, E. J. (2002). Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels. Clinical Genetics, 61, 176–184.10.1034/j.1399-0004.2002.610302.x
   Google Scholar
• Lewis, G. F., & Rader, D. J. (2005). New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circulation Research, 96, 1221–1232.10.1161/01.RES.0000170946.56981.5c
   Google Scholar
• Marcil, M., Boucher, B., Gagne, E., Davignon, J., Hayden, M., & Jenest, J. (1996). Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects. Journal of Lipid Research, 37, 309–319.
   Google Scholar
• Ordovas, J. M., Corella, D., Cupples, L. A., Demissie, S., Kelleher, A., Coltell, O., … Tucker, K. (2002). Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: The Framingham Study. The American Journal of Clinical Nutrition, 75, 38–46.
   Google Scholar
• Pagani, F., Sidoli, A., Giudici, G. A., Barenghi, L., Vergani, C., & Baralle, F. E. (1990). Human apolipoprotein A-I gene promoter polymorphism: Association with hyperalphalipoproteinemia. Journal of Lipid Research, 31, 1371–1377.
   Google Scholar
• Paul-Hayase, H., Rosseneu, M., Robinson, D., Van Bervliet, J. P., Deslypere, J. P., & Humphries, S. E. (1992). Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: Detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Human Genetics, 88, 439–446.10.1007/BF00215679
   Google Scholar
• Paulweber, B., Friedl, W., Krempler, F., Humphrie, S. E., & Sandhofer, F. (1988). Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease. Atherosclerosis, 73, 125–133.10.1016/0021-9150(88)90033-0
   Google Scholar
• Poduri, A., Khullar, M., Bahl, A., Sharma, Y. P., & Talwar, K. K. (2009). A combination of proatherogenic single-nucleotide polymorphisms is associated with increased risk of coronary artery disease and myocardial infarction in Asian Indians. DNA and Cell Biology, 28, 451–460.10.1089/dna.2009.0887
   Google Scholar
• Price, W. H., Morris, S. W., Burgon, R., Donald, P. M., & Kitchin, A. H. (1986). Apolipoprotein CIII polymorphism and coronary heart disease. The Lancet, 328, 1041.10.1016/S0140-6736(86)92652-8
   Google Scholar
• Pulkkinen, A., Viitanen, L., Kareinen, A., Lehto, S., & Laakso, M. (2000). MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care, 23, 791–795.10.2337/diacare.23.6.791
   Google Scholar
• Rees, A., Stocks, J., Sharpe, C. R., Vella, M. A., Shoulders, C. C., Katz, J., … Galton, D. J. (1985). Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia. Journal of Clinical Investigation, 76, 1090–1095.10.1172/JCI112062
   Google Scholar
• Saha, N., Wang, G., Vasisht, S., & Kamboh, M. I. (1997). Influence of two apo A4 polymorphisms at codons 347 and 360 on non-fasting plasma lipoprotein-lipids and apolipoproteins in Asian Indians. Atherosclerosis, 131, 249–255.10.1016/S0021-9150(97)06112-1
   Google Scholar
• Sankaranarayanan, K., Chakraborty, R., & Boerwinkle, E. A. (1999). Ionizing radiation and genetic risks. Mutation Research/Reviews in Mutation Research, 436, 21–57.10.1016/S1383-5742(98)00017-9
   Google Scholar
• Sherman, J. R., & Weinberg, R. B. (1988). Serum apolipoprotein A-IV and lipoprotein cholesterol in patients undergoing total parenteral nutrition. Gastroenterology, 95, 394–401.10.1016/0016-5085(88)90496-9
   Google Scholar
• Singh, P., Singh, M., Gaur, S., & Kaur, T. (2007). The ApoAI-CIII-AIV gene cluster and its relation to lipid levels in type 2 diabetes mellitus and coronary heart disease: Determination of a novel susceptible haplotype. Diabetes & Vascular Disease Research: Official Journal of the International Society of Diabetes and Vascular Disease, 4, 124–129.10.3132/dvdr.2007.030
   Google Scholar
• Singh, P., Singh, M., Kaur, T. P., & Grewal, S. S. (2008). A novel haplotype in ApoAI-CIII-AIV gene region is detrimental to Northwest Indians with coronary heart disease. International Journal of Cardiology, 130, e93–e95.10.1016/j.ijcard.2007.07.029
   Google Scholar
• Souverein, O. W., Jukema, J. W., Boekholdt, S. M., Zwinderman, A. H., & Tanck, M. W. (2005). Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD. European Journal of Human Genetics, 13, 445–451.10.1038/sj.ejhg.5201362
   Google Scholar
• Steinmetz, A., & Utermann, G. (1985). Activation of lecithin: Cholesterol acyltransferase by human apolipoprotein A-IV. Journal of Biological Chemistry, 260, 2258–2264.
   Google Scholar
• Vavatsi, N. A., Kouidou, S. A., Geleris, P. N., Tachmatzidis, C., Gikas, T., Tsifodimos, D. K., & Trakatellis, A. C. (1995). Increased frequency of the rare PstI allele (P2) in a population of CAD patients in northern Greece. Clinical Genetics, 47, 22–26.
   Google Scholar
• Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985). Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. Journal of Clinical Investigation, 75, 384–390.10.1172/JCI111711
   Google Scholar
• Wang, X. L., Badenhop, R., Humphrey, K. E., & Wilcken, D. E. (1996). New MspI polymorphism at +83 bp of the human apolipoprotein al gene: Association with increased circulating high density lipoprotein cholesterol levels. Genetic Epidemiology, 13, 1–10.10.1002/(ISSN)1098-2272
   Google Scholar
• Wang, G. Q., DiPietro, M., Roeder, K., Heng, C. K., Bunker, C. H., Hamman, R. F., & Kamboh, M. I. (2003). Cladistic analysis of human apolipoprotein A4 polymorphisms in relation to quantitative plasma lipid risk factors of coronary heart disease. Annals of Human Genetics, 67, 107–124.10.1046/j.1469-1809.2003.00023.x
   Google Scholar
• Weinberg, R. B. (2002). Apolipoprotein A-IV polymorphisms and diet-gene interactions. Current Opinion in Lipidology, 13, 125–134.10.1097/00041433-200204000-00003
   Google Scholar
• Wong, W. M., Hawe, E., Li, L. K., Miller, G. J., Nicaud, V., Pennacchio, L. A., … Talmud, P. J. (2003). Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels. Circulation Research, 92, 969–975.10.1161/01.RES.0000069688.94567.7A
   Google Scholar
• Xu, C. F., Talmud, P., Schuster, H., Houlston, R., Miller, G., & Humphries, S. (1994). Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia. Clinical Genetics, 46, 385–397.
   Google Scholar
• Zeng, Q., Dammerman, M., Takada, Y., Matsunaga, A., Breslow, J. L., & Sasaki, J. (1995). An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Human Genetics, 95, 371–375.
   Google Scholar